{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:12:19Z","timestamp":1785388339112,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.7759\/cureus.65819","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:25:45Z","timestamp":1722417945000},"source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Factors in Uterine Sarcoma Based on the Tumor Size Stratification: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Fumio","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Morisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Momomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D'Angelo E","year":"2010","unstructured":"D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010, 116:131-9. 10.1016\/j.ygyno.2009.09.023","journal-title":"Gynecol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO staging for uterine sarcomas","volume":"104","author":"Prat J","year":"2009","unstructured":"Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009, 104:177-8. 10.1016\/j.ijgo.2008.12.008","journal-title":"Int J Gynaecol Obstet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2012.689111","article-title":"Diagnosis and treatment of sarcoma of the uterus. A review","volume":"51","author":"Trop\u00e9 CG","year":"2012","unstructured":"Trop\u00e9 CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012, 51:694-705. 10.3109\/0284186X.2012.689111","journal-title":"Acta Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.10.044","article-title":"The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital","volume":"92","author":"Dinh TA","year":"2004","unstructured":"Dinh TA, Oliva EA, Fuller AF Jr, Lee H, Goodman A. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol. 2004, 92:648-52. 10.1016\/j.ygyno.2003.10.044","journal-title":"Gynecol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5436","article-title":"Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases","volume":"74","author":"Mayerhofer K","year":"1999","unstructured":"Mayerhofer K, Obermair A, Windbichler G, et al.. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999, 74:196-201. 10.1006\/gyno.1999.5436","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14436","article-title":"Endometrial stromal sarcoma: a review of rare mesenchymal uterine neoplasm","volume":"46","author":"Capozzi VA","year":"2020","unstructured":"Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: a review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res. 2020, 46:2221-36. 10.1111\/jog.14436","journal-title":"J Obstet Gynaecol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.03.001","article-title":"Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients","volume":"133","author":"Mancari R","year":"2014","unstructured":"Mancari R, Signorelli M, Gadducci A, et al.. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients. Gynecol Oncol. 2014, 133:531-6. 10.1016\/j.ygyno.2014.03.001","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"Kapp DS","year":"2008","unstructured":"Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008, 112:820-30. 10.1002\/cncr.23245","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/02841869009126543","article-title":"Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981","volume":"29","author":"Larson B","year":"1990","unstructured":"Larson B, Silfversw\u00e4rd C, Nilsson B, Pettersson F. Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981. Acta Oncol. 1990, 29:185-91. 10.3109\/02841869009126543","journal-title":"Acta Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.06.002","article-title":"Prognostic factors in uterine sarcoma","volume":"25","author":"Gadducci A","year":"2011","unstructured":"Gadducci A. Prognostic factors in uterine sarcoma. Best Pract Res Clin Obstet Gynaecol. 2011, 25:783-95. 10.1016\/j.bpobgyn.2011.06.002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.08.010","article-title":"Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma","volume":"100","author":"Wu TI","year":"2006","unstructured":"Wu TI, Chang TC, Hsueh S, Hsu KH, Chou HH, Huang HJ, Lai CH. Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol Oncol. 2006, 100:166-72. 10.1016\/j.ygyno.2005.08.010","journal-title":"Gynecol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler VM","year":"2009","unstructured":"Abeler VM, R\u00f8yne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009, 54:355-64. 10.1111\/j.1365-2559.2009.03231.x","journal-title":"Histopathology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1989.tb03341.x","article-title":"Revised FIGO staging for gynaecological cancer","volume":"96","author":"Shepherd JH","year":"1989","unstructured":"Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol. 1989, 96:889-92. 10.1111\/j.1471-0528.1989.tb03341.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102378","article-title":"Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022\/QCGC1302 study)","volume":"13","author":"Tse KY","year":"2021","unstructured":"Tse KY, Wong RW, Chao A, et al.. Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022\/QCGC1302 study). Cancers (Basel). 2021, 13:2378. 10.3390\/cancers13102378","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study","volume":"145","author":"Seagle BL","year":"2017","unstructured":"Seagle BL, Sobecki-Rausch J, Strohl AE, Shilpi A, Grace A, Shahabi S. Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study. Gynecol Oncol. 2017, 145:61-70. 10.1016\/j.ygyno.2017.02.012","journal-title":"Gynecol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.01.022","article-title":"Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma","volume":"157","author":"Takehara K","year":"2020","unstructured":"Takehara K, Yamashita N, Watanabe R, et al.. Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma. Gynecol Oncol. 2020, 157:115-20. 10.1016\/j.ygyno.2020.01.022","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2014.55.3.563","article-title":"FIGO staging for uterine sarcomas: can the revised 2008 staging system predict survival outcome better?","volume":"55","author":"Yim GW","year":"2014","unstructured":"Yim GW, Nam EJ, Kim SW, Kim YT. FIGO staging for uterine sarcomas: can the revised 2008 staging system predict survival outcome better?. Yonsei Med J. 2014, 55:563-9. 10.3349\/ymj.2014.55.3.563","journal-title":"Yonsei Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10129-x","article-title":"Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study","volume":"22","author":"Wang F","year":"2022","unstructured":"Wang F, Dai X, Chen H, Hu X, Wang Y. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study. BMC Cancer. 2022, 22:1050. 10.1186\/s12885-022-10129-x","journal-title":"BMC Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5014","article-title":"Development and validation of tumor-size-stratified prognostic nomograms for patients with uterine sarcoma: a SEER database analysis","volume":"12","author":"Cao S","year":"2023","unstructured":"Cao S, Liao X, Xu K, et al.. Development and validation of tumor-size-stratified prognostic nomograms for patients with uterine sarcoma: a SEER database analysis. Cancer Med. 2023, 12:1339-49. 10.1002\/cam4.5014","journal-title":"Cancer Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181e9d0ba","article-title":"Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study","volume":"20","author":"Garg G","year":"2010","unstructured":"Garg G, Shah JP, Liu JR, Bryant CS, Kumar S, Munkarah A, Morris RT. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study. Int J Gynecol Cancer. 2010, 20:1201-6. 10.1111\/IGC.0b013e3181e9d0ba","journal-title":"Int J Gynecol Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli RL","year":"2003","unstructured":"Giuntoli RL, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003, 89:460-9. 10.1016\/s0090-8258(03)00137-9","journal-title":"Gynecol Oncol"},{"key":"ref22","unstructured":"NCCN guidelines. Accessed. April 19, 2024: https:\/\/www.nccn.org\/guidelines\/guidelines-detail."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.08.037","article-title":"Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?","volume":"131","author":"Ricci S","year":"2013","unstructured":"Ricci S, Giuntoli RL 2nd, Eisenhauer E, et al.. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?. Gynecol Oncol. 2013, 131:629-33. 10.1016\/j.ygyno.2013.08.037","journal-title":"Gynecol Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1524-z","article-title":"The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure","volume":"282","author":"Dafopoulos A","year":"2010","unstructured":"Dafopoulos A, Tsikouras P, Dimitraki M, Galazios G, Liberis V, Maroulis G, Teichmann AT. The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure. Arch Gynecol Obstet. 2010, 282:293-300. 10.1007\/s00404-010-1524-z","journal-title":"Arch Gynecol Obstet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)","volume":"44","author":"Reed NS","year":"2008","unstructured":"Reed NS, Mangioni C, Malmstr\u00f6m H, et al.. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008, 44:808-18. 10.1016\/j.ejca.2008.01.019","journal-title":"Eur J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.12.008","article-title":"Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer\u00ae-accredited facilities","volume":"157","author":"Vaz J","year":"2020","unstructured":"Vaz J, Tian C, Richardson MT, et al.. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer\u00ae-accredited facilities. Gynecol Oncol. 2020, 157:121-30. 10.1016\/j.ygyno.2019.12.008","journal-title":"Gynecol Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0124","article-title":"Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers","volume":"17","author":"Tan PS","year":"2012","unstructured":"Tan PS, Koh E, Pang C, et al.. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers. Oncologist. 2012, 17:1286-93. 10.1634\/theoncologist.2012-0124","journal-title":"Oncologist"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.06.002","article-title":"Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001","volume":"111","author":"Koivisto-Korander R","year":"2008","unstructured":"Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Gynecol Oncol. 2008, 111:74-81. 10.1016\/j.ygyno.2008.06.002","journal-title":"Gynecol Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.01.022","article-title":"Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis","volume":"121","author":"D'Angelo E","year":"2011","unstructured":"D'Angelo E, Espinosa I, Ali R, Gilks CB, Rijn Mv, Lee CH, Prat J. Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis. Gynecol Oncol. 2011, 121:328-33. 10.1016\/j.ygyno.2011.01.022","journal-title":"Gynecol Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw030","article-title":"Progesterone receptor expression is an independent prognosticator in FIGO stage I uterine leiomyosarcoma","volume":"145","author":"Davidson B","year":"2016","unstructured":"Davidson B, Kj\u00e6reng ML, F\u00f8rsund M, Danielsen HE, Kristensen GB, Abeler VM. Progesterone receptor expression is an independent prognosticator in FIGO stage I uterine leiomyosarcoma. Am J Clin Pathol. 2016, 145:449-58. 10.1093\/ajcp\/aqw030","journal-title":"Am J Clin Pathol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0148","article-title":"Developing novel genomic risk stratification models in soft tissue and uterine leiomyosarcoma","volume":"30","author":"Dermawan JK","year":"2024","unstructured":"Dermawan JK, Chiang S, Singer S, et al.. Developing novel genomic risk stratification models in soft tissue and uterine leiomyosarcoma. Clin Cancer Res. 2024, 30:2260-71. 10.1158\/1078-0432.CCR-24-0148","journal-title":"Clin Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261567-prognostic-factors-in-uterine-sarcoma-based-on-the-tumor-size-stratification-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:25:48Z","timestamp":1722417948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261567-prognostic-factors-in-uterine-sarcoma-based-on-the-tumor-size-stratification-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.65819","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}